Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy. It Is Worth To Decide!

Agnė Čižauskaitė, Donatas Petrauskas, Dainius Šimčikas, Alvydas Česas Abstract Objective. To evaluate the predictable percentage of patients that could be eligible for sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy (NAC) in Klaipeda University Hospital Breast Surgery Department. Background. Although SLNB is a standard staging method for axillar node status assessment for early- stage clinically…

Sentinel Lymph Node Biopsy In Case Of Malignant Melanoma. First Experience Of Klaipeda University Hospital

Agnė Čižauskaitė, Donatas Petrauskas, Gintaras Gelžinis, Marija Sakalauskaitė, Alvydas Česas Abstract Melanoma is a malignant cutaneous disease that has the highest mortality among all the cancers of the skin. The incidence of this malignancy is increasing worldwide. Sentinel lymph node biopsy for IB and II stage melanoma is established as a standard treatment. Though there…